East African countries plan joint drug procurement to avoid high prices; Kenya hits anti-virals shortage

23 February 2010

Member states of the East African Community (EAC) plan to jointly procure drugs to avoid high prices and counterfeit drugs, Uganda's First Deputy Prime Minister, Eriya Kategaya, has revealed. Mr Kategaya, speaking at a meeting in Kampala last week which included Kenyan Health Minister Beth Mugo, director general of ESCA health community Hellen Igombeko and other officials, said procurement of drugs in bulk would resolve challenges associated with procurement and supply chains of essential medicines, reports New Vision.

"These are initiatives which can be strengthened and expanded to cover the central and southern African regions," he said, opening a five-day conference for the 14 member states of east, central and southern African health community (ECSA) at the Serena Hotel in Kampala.

Crisis looms in Kenya as surge in HIV patients drains drug stocks

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical